10/09/2026
Starting a pharmaceutical business doesn’t automatically mean manufacturing medicine yourself or investing in a production facility.
One potentially lower-capital route is to enter the supply chain as an importer or wholesaler.
But the biggest mistake is buying stock first and figuring out compliance later.
The way to keep startup costs down is to map the regulatory and commercial pathway before spending money on premises, inventory or supplier commitments.
At HCPA, we help businesses assess the opportunity, determine the correct regulatory pathway, establish the required quality and compliance systems, prepare applications and supporting documentation, respond to regulators and prepare for market entry.
Then, once operational, we can help identify product opportunities, customers, overseas suppliers and Australian distribution partnerships.
Start with the pathway. Spend once you know exactly what the business needs.